Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by GAMMA Investing LLC

GAMMA Investing LLC raised its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 9,318.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 163,412 shares of the company's stock after purchasing an additional 161,677 shares during the quarter. GAMMA Investing LLC owned about 0.09% of Doximity worth $9,483,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. increased its stake in Doximity by 4.5% during the 4th quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company's stock valued at $598,159,000 after purchasing an additional 485,102 shares in the last quarter. FMR LLC increased its stake in Doximity by 37.6% during the 4th quarter. FMR LLC now owns 9,409,313 shares of the company's stock valued at $502,363,000 after purchasing an additional 2,571,580 shares in the last quarter. Geode Capital Management LLC increased its stake in Doximity by 3.3% during the 4th quarter. Geode Capital Management LLC now owns 2,952,442 shares of the company's stock valued at $157,668,000 after purchasing an additional 95,458 shares in the last quarter. Loomis Sayles & Co. L P boosted its holdings in shares of Doximity by 2.7% in the 4th quarter. Loomis Sayles & Co. L P now owns 2,334,597 shares of the company's stock valued at $124,644,000 after acquiring an additional 62,366 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in shares of Doximity by 9.8% in the 4th quarter. Renaissance Technologies LLC now owns 1,847,702 shares of the company's stock valued at $98,649,000 after acquiring an additional 164,200 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Insider Buying and Selling

In related news, CFO Anna Bryson sold 45,000 shares of the firm's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the completion of the sale, the chief financial officer now directly owns 357,165 shares in the company, valued at approximately $20,440,552.95. This trade represents a 11.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the sale, the director now owns 16,618 shares of the company's stock, valued at approximately $946,062.74. The trade was a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 51,000 shares of company stock worth $2,900,770. Insiders own 37.40% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on DOCS shares. Mizuho dropped their price objective on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a report on Friday, May 16th. Truist Financial lowered their price target on shares of Doximity from $58.00 to $52.00 and set a "hold" rating on the stock in a report on Friday, May 16th. JPMorgan Chase & Co. lowered their price target on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a report on Tuesday, May 27th. Raymond James lowered their price target on shares of Doximity from $83.00 to $65.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Finally, KeyCorp lowered their price target on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Eleven investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $62.84.

Doximity Trading Down 1.8%

NASDAQ DOCS traded down $1.05 on Wednesday, reaching $57.49. 2,011,951 shares of the company were exchanged, compared to its average volume of 2,138,535. The business's fifty day moving average price is $54.93 and its 200 day moving average price is $58.36. The stock has a market capitalization of $10.80 billion, a P/E ratio of 57.49, a price-to-earnings-growth ratio of 4.10 and a beta of 1.32. Doximity, Inc. has a fifty-two week low of $25.00 and a fifty-two week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the previous year, the company earned $0.25 earnings per share. The company's revenue for the quarter was up 17.1% compared to the same quarter last year. Equities research analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.